Pharmacological, Biochemical and Immunological Studies on Protective Effect of Mangiferin in 6-Hydroxydopamine (6-OHDA)-Induced Parkinson's Disease in Rats

Overview

Journal Ann Neurosci

Publisher Sage Publications

Specialty Neurology

Date 2022 Mar 28

PMID 35341236

Authors

Prafulla Chandra Tiwari

Manju J Chaudhary

Rishi Pal

Shipra Kartik

Rajendra Nath

Affiliations

Soon will be listed here.

Abstract

Background: Parkinson's disease is a neurodegenerative disorder and is marked by inflammation and death of neurons in the striatum region of the midbrain. It has been reported that expression of NF-κB increases during Parkinson's disease, which promotes oxidative stress, stimulates release of proinflammatory cytokines, and induces expression of nitric oxide. Therefore, in this study, we have used mangiferin a specific NF-κB inhibitor. Mangiferin is a polyphenolic compound traditionally used for its antioxidant and anti-inflammatory properties.

Methods: The study utilized male Wistar rats weighing 200-250 g (56 rats; = 8/group). On day "0," stereotaxic surgery of rats was done to induce 6-hydroxydopamine lesioning in rats. Coordinates for substantia nigra were anteroposterior-2 mm, mediolateral-5 mm and dorsoventral-8.2 mm. After 14 days, those rats which show at least 210 contralateral rotations after administration of apomorphine (0.5 mg/kg S.C.) were selected for the study and were given treatment for 28 days. On day 28 of treatment, rats were subjected to behavioral studies to evaluate the effect of mangiferin and their brains were taken out after euthanasia to perform biochemical, molecular and immunological studies.

Results: Treatment with mangiferin significantly improves the key parameters of locomotor activity and oxidative stress and reduces the parameters of inflammatory stress. Also, the activity of caspases was reduced. Significant decrease in activity of both cyclooxygenase 1 and 2 was also observed. Maximum improvement in all parameters was observed in rats treated with grouping of mangiferin 45 µg/kg and levodopa 10 mg/kg. Treatment with levodopa alone has no significant effect on biochemical and molecular parameters though it significantly improves behavioral parameters.

Conclusion: Current treatment of Parkinson's disease does not target progression of Parkinson's disease. Results of this study suggest that mangiferin has protective effect in hemi-Parkinsonian rats. Therefore, the combination therapy of mangiferin and levodopa can be helpful in management of Parkinson's disease.

Citing Articles

Modulation of Autophagy and Nitric Oxide Signaling via Glycyrrhizic Acid and 7-Nitroindazole in MPTP-induced Parkinson's Disease Model.

Kartik S, Pal R, Chaudhary M, Nath R, Kumar M Ann Neurosci. 2025; 31(4):265-276.

PMID: 39840143 PMC: 11744622. DOI: 10.1177/09727531231191661.

New class of thio/semicarbazide-based benzyloxy derivatives as selective class of monoamine oxidase-B inhibitors.

Chandran N, Lee J, Prabhakaran P, Kumar S, Sudevan S, Parambi D Sci Rep. 2024; 14(1):31292.

PMID: 39732801 PMC: 11682371. DOI: 10.1038/s41598-024-82771-3.

Mangiferin potentiates the activity of antifungal agents against fluconazole-resistant spp.

Ferreira T, Leitao A, da Silva L, Sa L, de Farias Cabral V, Rodrigues D Future Microbiol. 2024; 19(13):1157-1170.

PMID: 39012219 PMC: 11529198. DOI: 10.1080/17460913.2024.2366627.

The effect of inhibiting hindbrain A2 noradrenergic neurons by 6-Hydroxydopamine on lipopolysaccharide-treated male rats autistic animal model.

Alhamami H, Albogami A, Algahtani M, Alqinyah M, Alanazi W, Alasmari F Saudi Pharm J. 2024; 32(3):101964.

PMID: 38328791 PMC: 10848015. DOI: 10.1016/j.jsps.2024.101964.

References

Mei S, Ma H, Chen X . Anticancer and anti-inflammatory properties of mangiferin: A review of its molecular mechanisms. Food Chem Toxicol. 2021; 149:111997. DOI: 10.1016/j.fct.2021.111997. View

Zhao F, Qu J, Wang W, Li S, Xu S . The imbalance of Th1/Th2 triggers an inflammatory response in chicken spleens after ammonia exposure. Poult Sci. 2020; 99(8):3817-3822. PMC: 7598003. DOI: 10.1016/j.psj.2020.04.029. View

Fahn S, Oakes D, Shoulson I, Kieburtz K, Rudolph A, Lang A . Levodopa and the progression of Parkinson's disease. N Engl J Med. 2004; 351(24):2498-508. DOI: 10.1056/NEJMoa033447. View

Sarkar A, Sreenivasan Y, Ramesh G, Manna S . beta-D-Glucoside suppresses tumor necrosis factor-induced activation of nuclear transcription factor kappaB but potentiates apoptosis. J Biol Chem. 2004; 279(32):33768-81. DOI: 10.1074/jbc.M403424200. View

Block M, Zecca L, Hong J . Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2006; 8(1):57-69. DOI: 10.1038/nrn2038. View

Imran M, Arshad M, Butt M, Kwon J, Arshad M, Sultan M . Mangiferin: a natural miracle bioactive compound against lifestyle related disorders. Lipids Health Dis. 2017; 16(1):84. PMC: 5414237. DOI: 10.1186/s12944-017-0449-y. View

Wu D, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C . Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci. 2002; 22(5):1763-71. PMC: 6758858. View

Emmanouil M, Taoufik E, Tseveleki V, Vamvakas S, Probert L . A role for neuronal NF-κB in suppressing neuroinflammation and promoting neuroprotection in the CNS. Adv Exp Med Biol. 2010; 691:575-81. DOI: 10.1007/978-1-4419-6612-4_60. View

Olsson M, Nikkhah G, Bentlage C, Bjorklund A . Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J Neurosci. 1995; 15(5 Pt 2):3863-75. PMC: 6578238. View

10.

Simola N, Morelli M, Carta A . The 6-hydroxydopamine model of Parkinson's disease. Neurotox Res. 2007; 11(3-4):151-67. DOI: 10.1007/BF03033565. View

11.

Bernstein A, Garrison S, Zambetti G, OMalley K . 6-OHDA generated ROS induces DNA damage and p53- and PUMA-dependent cell death. Mol Neurodegener. 2011; 6(1):2. PMC: 3025875. DOI: 10.1186/1750-1326-6-2. View

12.

Beinke S, Ley S . Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem J. 2004; 382(Pt 2):393-409. PMC: 1133795. DOI: 10.1042/BJ20040544. View

13.

Pal R, Gulati K, Banerjee B, Ray A . Pharmacological and biochemical studies on the protective effects of melatonin during stress-induced behavioral and immunological changes in relation to oxidative stress in rats. Can J Physiol Pharmacol. 2016; 94(3):296-301. DOI: 10.1139/cjpp-2015-0240. View

14.

Deumens R, Blokland A, Prickaerts J . Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol. 2002; 175(2):303-17. DOI: 10.1006/exnr.2002.7891. View

15.

Bales K, Du Y, Dodel R, Yan G, Paul S . The NF-kappaB/Rel family of proteins mediates Abeta-induced neurotoxicity and glial activation. Brain Res Mol Brain Res. 1998; 57(1):63-72. DOI: 10.1016/s0169-328x(98)00066-7. View

16.

Salat D, Tolosa E . Levodopa in the treatment of Parkinson's disease: current status and new developments. J Parkinsons Dis. 2013; 3(3):255-69. DOI: 10.3233/JPD-130186. View

17.

Zhang B, Zhao J, Li S, Yang L, Zeng L, Chen Y . Mangiferin activates Nrf2-antioxidant response element signaling without reducing the sensitivity to etoposide of human myeloid leukemia cells in vitro. Acta Pharmacol Sin. 2013; 35(2):257-66. PMC: 4651226. DOI: 10.1038/aps.2013.165. View

18.

Bajpai V, Alam M, Quan K, Kwon K, Ju M, Choi H . Antioxidant efficacy and the upregulation of Nrf2-mediated HO-1 expression by (+)-lariciresinol, a lignan isolated from Rubia philippinensis, through the activation of p38. Sci Rep. 2017; 7:46035. PMC: 5380954. DOI: 10.1038/srep46035. View

19.

Sierra A, Abiega O, Shahraz A, Neumann H . Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis. Front Cell Neurosci. 2013; 7:6. PMC: 3558702. DOI: 10.3389/fncel.2013.00006. View

20.

Li X, Sui C, Chen Q, Zhuang Y, Zhang H, Zhou X . The effects and mechanism of estrogen on rats with Parkinson's disease in different age groups. Am J Transl Res. 2016; 8(10):4134-4146. PMC: 5095307. View